Skip to product information
1 of 4
Micro Medical Pulmolife COPD Screening Device video Play video
Micro Medical Pulmolife COPD Screening Device video Play video

Micro Medical

Micro Medical Pulmolife COPD Screening Device

Micro Medical Pulmolife COPD Screening Device

Regular price £199.19 inc.VAT
£165.99 ex.VAT
Regular price £0.00 Sale price £199.19 inc.VAT
£165.99 ex.VAT
Sale Sold out




  • fileProduct Brochure Micro Medical Pulmolife.pdf


FREE STANDARD SHIPPING available on orders over £25 ex.VAT

Next working day - available until 8pm Monday to Friday
Weekend despatchavailable until 12pm Sunday for MONDAY delivery (Next working day)
Sat and Sunday delivery service - available until 5pm Friday.

Why buy from Medisave?

Medisave supplies health professionals, business and home users.

  • Credit card, PayPal and Amazon Payments accepted
  • Free delivery over £25 ex VAT
  • NHS, school or company purchase order - email
  • Laser engraving
  • Delivery to private or commercial addresses
  • Google Certified Shop
  • Registered with the Medicines and Healthcare products Regulatory Agency (MHRA)
  • ISO9001 quality management system + ISO 140001 environmental
  • Established 1999

Need some advice? Speak to our friendly team on 0800 804 6447

View full details

Quick and simple COPD screening in adult smokers

The device features a clear LCD display which displays a choice of parameters including % of predicted FEV1. The screen can also show an image of a male or female smoker illustrating the damage that can be caused by smoking.The PulmoLife COPD Screening and Lung Age Meter offers a quick and simple approach to screening adult smokers for the symptoms of COPD and is perfect for use by GPs in the surgery or on home visits.

The PulmoLife can save time and money by rapidly identifying patients who may require a full spirometry test.

Suitable for:

  • FEV1 testing programs;
  • Identification of early signs of COPD in smokers over 40 or anyone with symptoms;
  • Helping susceptible smokers to quit;

FEV1 and FEV1 % predicted:

Forced Expiratory Volume in the First Second of Expiration. The use of FEV1 is well documented as a useful diagnostic tool for the detection of early COPD. When comparing its result against predicted values and using patients FEV1 result as a percentage of predicted values (FEV1 % predicted) the likelihood and severity of COPD can be seen.

‘Lung Age’:

In addition to comparing patients FEV1 results with the predicted reference values for normal subjects, estimation of ‘Lung Age’ can be used to demonstrate to smokers the damage caused to their lungs by smoking in a way they can understand. The ‘Lung Age’ estimation is based on a patients FEV1 results and predicted values. A ‘Lung Age’ example; a 40 year old 5’9" (1.75m) male smoker has an FEV1 of 3.4L giving an estimated ‘Lung Age’ of 52 years. This is because the FEV1 is 100% of the predicted value that a 52 year old would be expected to get.


  • Simple, fast operation;
  • Clear LCD display;
  • % Predicted FEV1;
  • Can identify patients who may require a full spirometry test;
  • Visual illustration of smoking damage;
  • Displays an accurate estimation of lung age;
  • Reliable and low-cost;


Transducer Digital Volume Transducer
Resolution 0.01L
Accuracy ±3% to ATS/ERS Standardization of Spirometry
Volume range 0 to 8L
Predicted Values ECCS; NHANES III; Asian (Chinese)
Weight 96g
Dimensions 131 x 59 x 38mm